DYNE-301

N/A

Report date: 2022/07/01 14:25:00

Base Information

Drug NameDYNE-301
Drug Alias NameDYNE301
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Fab fragment
Mechanisms of ActionDouble Homeobox 4 Like 1 inhibitorsRNA interference
TargetsDouble Homeobox 4 Like 1
Therapy Area/IndicationsMuscular Dystrophy, Facioscapulohumeral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDyne Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDyne Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Facioscapulohumeral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A